0002-8870 : Omvoh 100 mg/ml Subcutaneous Injection, Solution
NDC: | 0002-8870 |
Labeler: | Eli Lilly and Company |
Product Type: | Human Prescription Drug |
Drug Name: | Omvoh |
Dosage Form: | Subcutaneous Injection, Solution |
Application #: | BLA761279 |
Rev. Date: |
NDC Package Codes:
- 0002-8870-27: 2 SYRINGE IN 1 CARTON (0002‑8870‑27) / 1 ML IN 1 SYRINGE (0002‑8870‑01)
Active Ingredients:
- Mirikizumab
Dosage Strength:
- 100 mg/mL
Pharmaceutical Classes:
- Interleukin-23 Antagonist [EPC]
- Interleukin-23 Antagonists [MoA]
Related Products:
Based on records with the same trade name.- 0002-7575 Omvoh 20 mg/ml Intravenous Injection, Solution by Eli Lilly and Company
- 0002-8011 Omvoh 100 mg/ml Subcutaneous Injection, Solution by Eli Lilly and Company
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 0002-8824Next: 0002-8900 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.